Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

Exosome-based treatments may improve skin and hair issues, but more research is needed for safety and effectiveness.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Nanotechnology could improve treatment for scars and atopic dermatitis by targeting skin issues more effectively.

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Co-trimoxazole may help treat autoimmune diseases.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

The silk fibroin-based hydrogel shows promise for treating melanoma and healing infected wounds by killing tumor cells and bacteria, and supporting skin recovery.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

Sex hormones influence immune responses and may help treat diseases.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Tridax procumbens may boost the immune system.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

No cure exists for alopecia areata; treatments aim to manage symptoms.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

JAK inhibitors can help treat alopecia areata but have risks and high costs.